Logo
  • Home
  • AI Agent
  • Annotations
  • Watchlists
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

Logo
PEN US​

Penumbra Inc(PEN US)

$324.39-0.570.18%Ext:$328.57+4.181.29%(Market Closed · 00:00:03 UTC)

Overview

ProfileEntity Structure

Documents

SEC Filings

Financials & Metrics

FinancialsChartingShort InterestEmployees

Penumbra Inc — Company Profile

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, Access25; MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, aspiration pump, and other components and accessories under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that include the Penumbra Coil 400, for the treatment of aneurysms and other complex lesions, detachable coils of neurovascular lesions under the Penumbra SMART COIL, SwiftSET, and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands. In addition, it provides peripheral embolization products, such as Ruby Embolization Platform, which consists of detachable coils for peripheral applications; Ruby LP and XL Embolization Platform; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; Packing Coil LP; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers neurosurgical tools comprising the Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. It sells its products through direct sales organizations and distributors. The company was incorporated in 2004 and is based in Alameda, California.

Sector
Industrials
Industry
Commercial Services & Supplies
Exchange
UN
CEO
Adam Elsesser
Headquarters
Alameda, CA, US
IPO Date
Sep 18, 2015
Employees
4,700
Website
www.penumbrainc.com

Key Metrics

Price
$317.55
Market Cap
$12.51B
Revenue (TTM)
$374.76M
Net Income (TTM)
$32.58M
EPS (TTM)
0.83
P/E (TTM)
73.13
P/B (TTM)
8.49
Dividend Yield
0.00%
ROE (TTM)
2.21%
ROA (TTM)
1.72%
Operating Margin
10.20%
Beta
0.01

Dividends

Last Dividend
$0.00
Last Yield
0.00%

Summary

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, Access25; MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, aspiration pump, and other components and accessories under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that include the Penumbra Coil 400, for the treatment of aneurysms and other complex lesions, detachable coils of neurovascular lesions under the Penumbra SMART COIL, SwiftSET, and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands. In addition, it provides peripheral embolization products, such as Ruby Embolization Platform, which consists of detachable coils for peripheral applications; Ruby LP and XL Embolization Platform; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; Packing Coil LP; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers neurosurgical tools comprising the Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. It sells its products through direct sales organizations and distributors. The company was incorporated in 2004 and is based in Alameda, California.

Website
www.penumbrainc.com
Location
Alameda, CA, US
Phone510 748 3200
Employees4,700
CEOAdam Elsesser
Sector
Industrials
Industry
Commercial Services & Supplies
IPO DateSep 18, 2015

Ask AI

Company overview
Business model, segments, and competition.
Peer comparison
Metrics vs closest competitors.
Guidance & outlook
Forward guidance and assumptions.
Bull vs bear case
Upside drivers and key risks.
Valuation snapshot
Multiples vs history and peers.
Competitive moat
Defensibility and market position.
Management track record
Leadership and capital allocation history.

Latest Documents

SEC Filings(941)

Expand
  • 4Statement of changes in beneficial ownership16 Oct
  • 4Statement of changes in beneficial ownership17 Sep
  • 4Statement of changes in beneficial ownership19 Aug
  • SC 13GPenumbra Inc13 Aug
  • 10-QQ2ended 30 Jun 202630 Jul
  • 8-KResults of Operations and Financial Condition30 Jul
  • 8-KSubmission of Matters to a Vote of Security Holders22 Jun
  • SDSD29 May
  • 4Statement of changes in beneficial ownership21 May
  • 425Business combination communication7 May
  • 8-KSubmission of Matters to a Vote of Security Holders7 May
  • 10-QQ1ended 31 Mar 20266 May
  • 8-KResults of Operations and Financial Condition6 May
  • SC 13GPenumbra Inc30 Apr
  • ARSAnnual report to security holders29 Apr
  • DEFA14ADefinitive additional materials29 Apr
  • DEF 14ADefinitive proxy statement29 Apr
  • 425Business combination communication23 Apr
  • 425Business combination communication22 Apr
  • 425Business combination communication17 Apr

News

  • Penumbra's CAVT Technology Receives FDA Clearance for the Treatment of Deep Vein Thrombosis (DVT)20 Oct
  • Penumbra (NYSE:PEN) Stock Breaks Above 50-Day Moving Average – Should You Sell?17 Oct
  • New STORM-PE Data Demonstrate Correlation Between Clinical Assessments and Real-world Functional Recovery Captured Through Wearable Technology in Patients with Pulmonary Embolism6 Oct
  • IART vs. PEN: Which Stock Is the Better Value Option?1 Oct
  • Penumbra (NYSE:PEN) Stock Price Breaks Below Fifty Day Moving Average – What’s Next?30 Sep
  • IART or PEN: Which Is the Better Value Stock Right Now?29 Sep
  • Reasons to Retain Penumbra Stock in Your Portfolio for Now16 Sep
  • TFX vs. PEN: Which Stock Is the Better Value Option?11 Sep
  • Connor Clark & Lunn Investment Management Ltd. Buys New Position in Penumbra, Inc. $PEN30 Aug
  • TFX or PEN: Which Is the Better Value Stock Right Now?26 Aug
  • TFX vs. PEN: Which Stock Is the Better Value Option?10 Aug
  • Penumbra, Inc. Reports Second Quarter 2026 Financial Results30 Jul
  • Bank of Nova Scotia Acquires 210,402 Shares of Penumbra, Inc. $PEN25 Jul

Mentions in Filings

  • #\*Peninsula Energy, Ltd. 559 358 \*PeopleIN, Ltd. 2,266 1,087 Perenti, Ltd. 163,195 321,257 Perpetual, Ltd. 7,089 89,938 Perseus Mining, Ltd. 156,126 645,307 \*PEXA Group, Ltd. 11,808 113,824
    Dimensional ETF TrustPenumbra Inc·NPORT-EX - NT NPORT-P - Notification of late filing (portfolio holdings)·Q1 26·13 Aug
  • … Ownership Percentage Eastern Shore Natural Gas Company Delaware Chesapeake Utilities Corporation 100% Sharp Energy, Inc. Delaware Chesapeake Utilities Corporation 100% Sharpgas, Inc. Delaware Sharp Energy, Inc. 100% <strong>Peninsula Energy</strong> Services Company, Inc. Delaware Chesapeake Utilities Corporation 100% Peninsula Pipeline Company, Inc. Delaware Chesapeake Utilities Corporation 100% Florida Public Utilities Company Florida Chesapeake Utilities Corp …
    CHESAPEAKE UTILITIES CORPPenumbra Inc·EX-10.1 - 10-Q - Quarterly report Q2·Q2 26·6 Aug
  • … oviex Uranium Inc. • Iluka Resources Limited • Image Resources • Kenmare Resources plc • Lynas Rare Earth Ltd. • MP Materials Corp. • Neo Performance Materials • NexGen Energy Ltd. • Paladin Energy Limited • <strong>Peninsula Energy</strong> Ltd. • Rare Element Resources Ltd. • Texas Mineral Resources Corp. • Tronox Holdings Plc • Ucore Rare Metals Inc. • Uranium Energy Corp. • Ur-Energy Inc. which, as of the time of the 2025 LTIP's implementation …
    ENERGY FUELS INCPenumbra Inc·DEF 14A - Definitive proxy statement·Q2 26·17 Apr
  • … Canada’s Athabasca Basin, widely recognized as the premier uranium jurisdiction globally. URC’s portfolio also provides exposure to near term cash flow through project restarts, such as the Lance Project, operated by <strong>Peninsula Energy</strong>, in Wyoming and the Langer Heinrich Mine in Namibia, operated by Paladin. Development-stage assets include projects such as Uranium Energy Corp’s Roughrider Project in Saskatchewan, Canada. URC provides both geograph …
    Uranium Royalty Corp.Penumbra Inc·EX-99.1 - 6-K - Current report (foreign private issuer)·Q4 26·16 Apr
  • … approximately 50 years. Mr. Jones was one of the early investors in U.S. shale gas. For approximately the past ten (10) years, Mr. Jones has served, and continues to serve, as the Chief Executive Officer of Fairwood <strong>Peninsula Energy</strong> Corporation (“Fairwood”), a midstream liquefied natural gas company. Fairwood is a material stockholder of our controlling stockholder, Delfin Midstream, Inc. (“Delfin”). Mr. Jones was a founder of Fairwood and is cu …
    THEGLOBE COM INCPenumbra Inc·10-K - Annual report FY 2025·FY25·31 Mar
  • … ep Yellow Ltd., Denison Mines, Eramet S.A., GoviEx, Iluka Resources Limited, Image Resources, Kenmare Resources Plc, Lynas Rare Earth Ltd., MP Materials Corp, Neo Performance Materials, NexGen Energy, Paladin Energy, <strong>Peninsula Energy</strong>, Rare Element Resources Ltd., Texas Mineral Resources Corp, Tronox Holdings Plc, Ucore Rare Metals Inc., Uranium Energy Corp and Ur-Energy. The chart shows yearly performance marks over a five-year period. This perfo …
    ENERGY FUELS INCPenumbra Inc·10-K - Annual report FY 2025·FY25·26 Feb

Key Stats

Trading

Px/Chg 1D$317.55 / -0.14%
Avg Volume526.00K
Beta0.01
Mkt Cap12.51B
FD Mkt Cap12.75B

Float

Shrs Out/Float39.39M / 38.29M
Short Float0.05%
Days to Cover5.10
Stock Repurchased$0.00

Current Valuation

EV12.48B
EV/EBITDA56.49
EV/Sales8.58
P/B8.49
P/S8.60
FCF Yield0.59%
ROE2.21%
ROA1.72%
Current Ratio6.02

Estimates

P/E73.13
Est P/EN/A
Est EPSN/A
Est PEGN/A

Valuation

Metric5Yr AvgMay '23May '24Apr '25May '26Oct '26
PRICE-BASED RATIOS
Price / Earnings-778.02-5,395.7789.35764.35268.09383.87
Price / Sales19.1412.757.688.9732.9333.38
Price / Book Value8.8810.816.899.318.898.49
Price / Free Cash Flow76.94-144.1198.9672.71186.51170.64
ENTERPRISE VALUE METRICS
Enterprise Value10,995.710,968.38,193.310,609.112,724.812,483.0
Enterprise Value / Sales19.1812.957.748.8833.0233.31
Enterprise Value / EBITDA225.41366.0775.41230.69186.87268.00
Enterprise Value / EBIT603.651,944.38100.67476.02199.98297.18

Financials

Full Financials
Millions USD5Yr CAGR (%)Dec '21Dec '22Dec '23Dec '24Dec '25
INCOME STATEMENT
Revenue17.1%747.6847.11,058.51,194.61,403.7
Gross Income18.7%475.4535.2682.6755.0942.4
EBITDA130.8%7.830.0108.646.0222.6
EBIT—-8.65.681.422.3205.1
Net Income140.8%5.3-2.091.014.0177.7
EPS (Diluted)138.4%0.14-0.052.320.364.52
BALANCE SHEET
Cash & ST Inv-7.5%254.9188.0289.2340.1186.9
Total Assets10.1%1,244.31,370.91,556.31,533.21,826.5
Total Liabilities8.3%290.3372.0377.4382.3398.9
Total Shareholder Equity10.6%953.9998.91,178.91,150.91,427.6
CASH FLOW
Net Operating Cash Flow123.9%9.5-55.797.3168.5238.7
Cap Ex31.7%-21.2-19.3-15.2-21.2-63.7
Free Cash Flow—-11.7-75.082.1147.3174.9

Enterprise Value Bridge

Millions USD23 Oct '26
Price (As of 23 Oct '26)324.79
Basic Shares39.39
Market Cap12,793.3
Diluted Shares39.54
Fully Diluted Shares Outstanding39.54
Fully Diluted Market Cap12,843.4
+Consolidated Debt216.2
−In-the-Money Convertible Debt—
+Capital Leases-
+Operating Leases—
−Cash & Equivalents-241.3
−Short-term Investments-
+Total Preferred-
−In-the-Money Convertible Preferred—
−Investments in Unconsolidated Subs—
+Non-Controlling Interest-
+Pension Liabilities—
Enterprise Value12,768.2

Segment data

Revenue

by Products and services

  • Peripheral Vascular59%
  • Neuro41%

Revenue

by Geography

  • United States78%
  • Non-us22%

Related companies

Apple Inc.

AAPL US

Kla Corp

KLAC US

Medtronic Public Limited Company

MDT US

Stryker Corp

SYK US

3M Company

MMM US

Northrop Grumman Corp /DE/

NOC US

Coherent Corp.

COHR US

Boston Scientific Corp

BSX US

Lenovo Group Ltd

LNVGY US

Garmin Ltd

GRMN US

HOYA Corporation

HOCPY US

Becton Dickinson & Co

0R19 LN